265 related articles for article (PubMed ID: 33479542)
1. Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.
Terlecki-Zaniewicz S; Humer T; Eder T; Schmoellerl J; Heyes E; Manhart G; Kuchynka N; Parapatics K; Liberante FG; Müller AC; Tomazou EM; Grebien F
Nat Struct Mol Biol; 2021 Feb; 28(2):190-201. PubMed ID: 33479542
[TBL] [Abstract][Full Text] [Related]
2. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
Hirose K; Abramovich C; Argiropoulos B; Humphries RK
Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
[TBL] [Abstract][Full Text] [Related]
3. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
[TBL] [Abstract][Full Text] [Related]
5. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.
Nakamura T
Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755
[TBL] [Abstract][Full Text] [Related]
6. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
[TBL] [Abstract][Full Text] [Related]
7. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
Funasaka T; Nakano H; Wu Y; Hashizume C; Gu L; Nakamura T; Wang W; Zhou P; Moore MA; Sato H; Wong RW
Cell Cycle; 2011 May; 10(9):1456-67. PubMed ID: 21467841
[TBL] [Abstract][Full Text] [Related]
8. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
[TBL] [Abstract][Full Text] [Related]
9. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
10. The role of NUP98 gene fusions in hematologic malignancy.
Slape C; Aplan PD
Leuk Lymphoma; 2004 Jul; 45(7):1341-50. PubMed ID: 15359631
[TBL] [Abstract][Full Text] [Related]
11. Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.
Sarma NJ; Yaseen NR
PLoS One; 2013; 8(6):e67032. PubMed ID: 23840580
[TBL] [Abstract][Full Text] [Related]
12. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.
Qiu JJ; Zeisig BB; Li S; Liu W; Chu H; Song Y; Giordano A; Schwaller J; Gronemeyer H; Dong S; So CW
Leukemia; 2015 May; 29(5):1153-62. PubMed ID: 25510432
[TBL] [Abstract][Full Text] [Related]
13. Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.
Chandra B; Michmerhuizen NL; Shirnekhi HK; Tripathi S; Pioso BJ; Baggett DW; Mitrea DM; Iacobucci I; White MR; Chen J; Park CG; Wu H; Pounds S; Medyukhina A; Khairy K; Gao Q; Qu C; Abdelhamed S; Gorman SD; Bawa S; Maslanka C; Kinger S; Dogra P; Ferrolino MC; Di Giacomo D; Mecucci C; Klco JM; Mullighan CG; Kriwacki RW
Cancer Discov; 2022 Apr; 12(4):1152-1169. PubMed ID: 34903620
[TBL] [Abstract][Full Text] [Related]
14. Trans-repressive effect of NUP98-PMX1 on PMX1-regulated c-FOS gene through recruitment of histone deacetylase 1 by FG repeats.
Bai XT; Gu BW; Yin T; Niu C; Xi XD; Zhang J; Chen Z; Chen SJ
Cancer Res; 2006 May; 66(9):4584-90. PubMed ID: 16651408
[TBL] [Abstract][Full Text] [Related]
15. The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.
Lavau CP; Aumann WK; Sze SK; Gupta V; Ripple K; Port SA; Kehlenbach RH; Wechsler DS
PLoS One; 2020; 15(4):e0232036. PubMed ID: 32343715
[TBL] [Abstract][Full Text] [Related]
16. Phase separation drives aberrant chromatin looping and cancer development.
Ahn JH; Davis ES; Daugird TA; Zhao S; Quiroga IY; Uryu H; Li J; Storey AJ; Tsai YH; Keeley DP; Mackintosh SG; Edmondson RD; Byrum SD; Cai L; Tackett AJ; Zheng D; Legant WR; Phanstiel DH; Wang GG
Nature; 2021 Jul; 595(7868):591-595. PubMed ID: 34163069
[TBL] [Abstract][Full Text] [Related]
17. NUP98 gene fusions in hematologic malignancies.
Lam DH; Aplan PD
Leukemia; 2001 Nov; 15(11):1689-95. PubMed ID: 11681408
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the NUP98-CCDC28A fusion protein.
Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
[TBL] [Abstract][Full Text] [Related]
19. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
Pineault N; Abramovich C; Ohta H; Humphries RK
Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
[TBL] [Abstract][Full Text] [Related]
20. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR
J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
